Issued 2026-09-16 at $3.15 · now $3.15 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, CINT has typically landed between $2.33 and $3.98 — a range of −26.1% to +26.3% from the issuance price $3.15.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,195 overlapping 1 month windows · 2021-11-10 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($3.15) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where CINT has typically landed a month from the 2026-09-16 close of $3.15 — the range is history, not a prediction.
- now $3.15 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $3.06 (-3.0%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $2.72–$3.39
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.33–$3.98
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2022-08-09 | −42.3% | −45.8% | +0.0% |
| 2022-08-08 | −41.5% | −43.5% | +4.3% |
| 2022-08-05 | −40.6% | −41.6% | +7.8% |
| 3 best | |||
| 2023-05-19 | +89.1% | +0.0% | +89.1% |
| 2023-05-15 | +82.3% | −0.9% | +82.3% |
| 2023-05-12 | +78.0% | −0.9% | +78.0% |
1,195 overlapping windows · 2021-11-10 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~5 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 | Guicardi Neto Bruno | officer | Purchase | 5,389 @ $3.21 | $17K | +6.3% of holding | not yet — horizon still open | not yet — horizon still open | 91,264 | Form 4 · filed 4 days after the trade |
| 2026-09-10 | Guicardi Neto Bruno | officer | Purchase | 100 @ $3.10 | $310 | +0.1% of holding | not yet — horizon still open | not yet — horizon still open | 85,875 | Form 4 · filed 5 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
22 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | Santana Maria Helena dos Santos Fernandes de | director | Award / grant | 8,040 | 8,040 | Form 4 |
| 2026-06-15 | Trematore Carla Alessandra | director | Award / grant | 8,040 | 8,040 | Form 4 |
| 2026-06-15 | MEIRA SILVIO ROMERO DE LEMOS | director | Award / grant | 5,360 | 5,360 | Form 4 |
| 2026-06-15 | gouveia eduardo campozana | director | Award / grant | 8,040 | 8,040 | Form 4 |
| 2026-06-15 | Rodrigues Stanley | officer | Award / grant | 33,718 | 33,718 | Form 4 |
| 2026-06-15 | Rodrigues Stanley | officer | Award / grant | 67,436 | 67,436 | Form 4 |
| 2026-05-01 | Santana Maria Helena dos Santos Fernandes de | director | Withheld for tax | 1,146 | 18,828 | Form 4 |
| 2026-05-01 | gouveia eduardo campozana | director | Withheld for tax | 1,146 | 3,670 | Form 4 |
| 2026-05-01 | Trematore Carla Alessandra | director | Withheld for tax | 765 | 12,735 | Form 4 |
| 2026-05-01 | MEIRA SILVIO ROMERO DE LEMOS | director | Withheld for tax | 764 | 2,014 | Form 4 |
| 2026-05-01 | MEIRA SILVIO ROMERO DE LEMOS | director | Option exercise | 2,778 | 0 | Form 4 |
| 2026-05-01 | Santana Maria Helena dos Santos Fernandes de | director | Option exercise | 4,166 | 0 | Form 4 |
| 2026-05-01 | gouveia eduardo campozana | director | Option exercise | 4,166 | 0 | Form 4 |
| 2026-05-01 | Trematore Carla Alessandra | director | Option exercise | 2,781 | 0 | Form 4 |
| 2026-05-01 | Trematore Carla Alessandra | director | Option exercise | 2,781 | 13,500 | Form 4 |
| 2026-05-01 | Santana Maria Helena dos Santos Fernandes de | director | Option exercise | 4,166 | 19,974 | Form 4 |
| 2026-05-01 | MEIRA SILVIO ROMERO DE LEMOS | director | Option exercise | 2,778 | 2,778 | Form 4 |
| 2026-05-01 | Trematore Carla Alessandra | director | Option exercise | 2,781 | 13,500 | Form 4 |
| 2026-05-01 | MEIRA SILVIO ROMERO DE LEMOS | director | Option exercise | 2,778 | 2,778 | Form 4 |
| 2026-05-01 | gouveia eduardo campozana | director | Option exercise | 4,166 | 4,816 | Form 4 |
| 2026-05-01 | Santana Maria Helena dos Santos Fernandes de | director | Option exercise | 4,166 | 19,974 | Form 4 |
| 2026-05-01 | gouveia eduardo campozana | director | Option exercise | 4,166 | 4,816 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.